LifeSource Vitamins
Rated 5.0 out of 5
2 Reviews

Head-Aid 508 mg - Liquid Extract - 1 fl. oz.

Original Price: $13.99   Current Price: $13.99
  • Supports relief from headaches and migraines*
  • Reduces tension and throbbing pain*
  • Promotes relaxation and stress relief*
  • Supports reduced inflammation with salicin*
  • Provides antioxidant support with Feverfew*
  • Non-GMO, gluten-free, alcohol-free, vegan liquid extract*
  • Fast absorption; mixes easily into water or juice*
  • 3rd-party lab tested for purity & potency
  • $10 off $75+ or $25 off $125+

    codes: JUNE10 or JUNE25

  • Free Shipping on orders over $99 (after discount)

Purchase options
Recurring Subscription

Pairs well with:

Product Details

Head-Aid Liquid — Supports Headache Comfort, Healthy Head Tension & Everyday Relief*

LifeSource Vitamins Head-Aid Liquid blends time-tested Botanicals to support headache comfort, healthy head tension, and day-to-day relief within a clean, alcohol-free format.* Produced in FDA-registered, GMP-certified facilities and guided by NIH/PubMed-indexed human research under FDA/FTC structure-function standards.*

Research-Driven & Verified Product.
Explore the clinical research, ingredient science, and global evidence supporting this product below.
Research Promise: At LifeSource Vitamins, our commitment is rooted in research and results. Every benefit below is supported by human clinical studies indexed in the National Institutes of Health (NIH) via PubMed, with full texts available in the National Library of Medicine (NLM) PubMed Central (PMC) when available. We also reference reviews from 39 leading health organizations and insights from 20 top global universities to keep our guidance aligned with credible, evidence-based science.* Every claim is supported by peer-reviewed human RCTs or meta-analyses whenever available.
Clinically Studied Benefits

Helps maintain healthy migraine frequency* — Standardized feverfew (MIG-99) supported migraine prevention in a randomized, double-blind, placebo-controlled multicenter trial. NIH/PubMed — Diener H, 2005

Supports head-comfort between episodes* — Dried feverfew leaf showed benefit in a double-blind, placebo-controlled crossover study for migraine prophylaxis. NIH/PubMed — Murphy JJ, 1988

Promotes everyday comfort in the back-pain model* — White willow bark extract improved short-term pain outcomes vs placebo in acute low-back pain. NIH/PubMed — Chrubasik S, 2000

Comparable relief to active control in low-back pain* — Willow bark performed similarly to a conventional anti-rheumatic in an RCT. NIH/PubMed — Chrubasik S, 2001

Helps maintain healthy migraine frequency* — White willow bark (salicin standardized) showed probable short-term improvements in pain and function in systematic review of RCTs for low-back pain model. NIH/PubMed — Oltean H, 2014

Supports short-term musculoskeletal comfort* — Herbal willow bark extract demonstrated moderate-quality evidence for short-term pain relief in low-back pain RCTs. NIH/PubMed — Oltean H, 2014

Promotes comfort in acute pain models* — Willow bark extract provided improvements comparable to reference anti-rheumatic in randomized controlled study for low-back pain. NIH/PubMed — Chrubasik S, 2001

Supports headache comfort in herbal contexts* — Combination approaches including feverfew and willow bark explored in open-label study for migraine prophylaxis. NIH/PubMed — Shrivastava R, 2006

Helps maintain reduced migraine attack frequency* — Nutraceutical combinations with feverfew showed potential benefits in observational and review contexts for migraine support. NIH/PubMed — Guilbot A, 2017

Contributes to overall herbal support for head comfort* — Systematic reviews indicate mixed but suggestive evidence for standardized feverfew in migraine prevention. NIH/PubMed — Wider B, 2015

Additional / Promising Evidence

Feverfew — Systematic review/meta-evidence notes mixed but suggestive findings depending on extract standardization and study design. NIH/PubMed — Wider B, 2015

White Willow Bark — Reviews indicate probable short-term pain improvements at standardized salicin doses. NIH/PubMed — Oltean H, 2014

Feverfew in combinations — Prospective observational study suggests potential benefit and safety for migraine prophylaxis with feverfew, CoQ10, and magnesium. NIH/PubMed — Guilbot A, 2017

Herbal treatments overall — Systematic review of RCTs shows mixed evidence for feverfew and positive limited evidence for related herbals in migraine. NIH/PubMed — Lopresti AL, 2020

Nutraceuticals for migraine — Review supports potential of herbal supplements including feverfew for reducing migraine frequency. NIH/PubMed — Kaur K, 2021

Willow bark in pain models — Moderate evidence from RCTs for short-term pain relief applicable to comfort support. NIH/PubMed — Oltean H, 2014

University-Led & Academic Studies

Academic headache research programs — Feverfew’s standardized extract (MIG-99) has been evaluated in multicenter university-affiliated trials for migraine prevention. NIH/PubMed — Diener H, 2005

Feverfew evaluation in rigorous trials — Cochrane systematic review (academic-led) assesses feverfew for migraine prevention with mixed but low-quality positive signals in larger trials. NIH/PubMed — Wider B, 2015

Herbal medicine for low-back pain — Cochrane review (university/academic collaborative) provides moderate evidence for willow bark in short-term pain support. NIH/PubMed — Oltean H, 2014

Global Evidence & Reviews

Global herbal analgesic reviews — Summaries discuss standardized willow bark for short-term musculoskeletal comfort; emphasize dose and salicin standardization. NIH/PubMed — Oltean H, 2014

Feverfew for preventing migraine — Authoritative Cochrane review notes mixed evidence requiring further confirmation for standardized extracts. NIH/PubMed — Wider B, 2015

Herbal treatments for migraine — Systematic review highlights feverfew among herbals with mixed RCT results for migraine support. NIH/PubMed — Lopresti AL, 2020

We monitor research from leading institutions — Harvard, Johns Hopkins, Mayo Clinic, Cleveland Clinic, Cambridge, Oxford, Stanford, Yale, Tufts, University of Florida, Oregon State University – Linus Pauling Institute, Columbia, Cornell, Ohio State — to align with credible science.*
Key Ingredients
  • Feverfew (Tanacetum parthenium) — Clinically studied for migraine prevention; activity associated with parthenolide-standardized extracts.
  • White Willow Bark (Salix alba) — Provides salicin-based support for everyday comfort.
  • Alcohol-Free Base — Vegan, non-GMO, gluten-free carrier system (quality statements when label-verified).
Brief Benefit Bullets
  • Supports headache comfort & healthy head tension*
  • Backed by NIH/PubMed-indexed human research on key botanicals*
  • Alcohol-free, vegan, non-GMO; produced in GMP-certified facilities*
  • Every batch 3rd-party tested for identity, purity & potency*
Suggested Use

Adults: Use as directed on the product label. Consult your physician if pregnant/nursing, allergic to salicylates, taking anticoagulants, or if you have a medical condition. Discontinue and consult a professional if adverse reactions occur. Keep out of reach of children.*

Product Specifications
  • Form — Liquid extract
  • Quality — Non-GMO, vegan, gluten-free*
3rd-Party Testing. Every batch is verified by independent labs for identity, purity, and potency. See our 3rd-party testing »

LifeSource Vitamins — Proudly American — Since 1992

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

LifeSource Vitamins Head-Aid Liquid — alcohol-free herbal support for headache comfort, healthy head tension & everyday relief; vegan, non-GMO, 3rd-party tested. Clinically Studied Ingredients — NIH/PubMed!*

You May Also Like